Myxoma Virus Optimizes Cisplatin for the Treatment of Ovarian Cancer In Vitro and in a Syngeneic Murine Dissemination Model-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Myxoma Virus Optimizes Cisplatin for the Treatment of Ovarian Cancer In Vitro and in a Syngeneic Murine Dissemination Model

Published:2017-09 Issue: Volume:6 Page:90-99
ISSN:2372-7705
Container-title:Molecular Therapy - Oncolytics
language:en
Short-container-title:Molecular Therapy - Oncolytics

Author:

Nounamo Bernice,Liem Jason,Cannon Martin,Liu Jia

Funder

Rivkin Center for Ovarian Cancer

UAMS Department of Microbiology and Immunology

Mayo Clinic SPORE in Ovarian Cancer

Microgrants for Collaborative Exploratory Research

MiCER

NIH

Translational Research Institute at UAMS

NIH COBRE Center for Microbial Pathogenesis and Host Inflammatory Responses

Publisher

Elsevier BV

Subject

Pharmacology (medical),Cancer Research,Oncology,Molecular Medicine

Reference49 articles.

1. The management of recurrent ovarian cancer;Bukowski;Semin. Oncol.,2007

2. Challenges for chemotherapy in ovarian cancer;Ozols;Ann. Oncol.,2006

3. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer;Zhang;N. Engl. J. Med.,2003

4. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival;Curiel;Nat. Med.,2004

5. Signaling circuits and regulation of immune suppression by ovarian tumor-associated macrophages;Cannon;Vaccines (Basel),2015

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antagonizing the SAMD9 pathway is key to myxoma virus host shut-off and immune evasion;2024-02-02

2. In Vitro and In Vivo Efficacy of a Stroma-Targeted, Tumor Microenvironment Responsive Oncolytic Adenovirus in Different Preclinical Models of Cancer;International Journal of Molecular Sciences;2023-06-10

3. Single CAR-T cell treatment controls disseminated ovarian cancer in a syngeneic mouse model;Journal for ImmunoTherapy of Cancer;2023-05

4. Oncolytic virotherapy: basic principles, recent advances and future directions;Signal Transduction and Targeted Therapy;2023-04-11

5. The role of viruses in cancer development versus cancer therapy: An oncological perspective;Cancer Medicine;2023-03-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3